Nuke, unfortunately because management is trying to get cheap options and are trying to implement RS (they could have done so for a year but haven't), there is no chance for pphm to ever realize a gain for existing shareholders. In fact, for the life of me I can't figure out why Dr. Chabner would ever agree to work with pphm in spite of the fact that Dr. Haynes from Duke has a collaboration, DTRA has signed one of there largest contacts with pphm, and there pps is up 300%+/- in the last year.
Forget it. There is a 100% chance we are all screwed.
News 
Market Data 
Discover 
